Mehta Vimal's Form 4 filing
BioXcel Therapeutics, Inc. (BTAIQ) · filed Sep 17, 2024
- Accession no.
- 0001104659-24-100751
- Filed
- Sep 17, 2024
- Trade date
- Sep 14-16, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.37K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mehta VimalCIK 0001733369 | Director, Officer (CEO and President), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2024 | Common Stock | MOption exerciseAcquired | +2,609 | – | – | 50,148 | Direct | |
| Sep 15, 2024 | Common Stock | MOption exerciseAcquired | +3,500 | – | – | 53,648 | Direct | |
| Sep 16, 2024 | Common Stock | SSaleDisposed | −832 | $0.69 | −$574.08 | 52,816 | Direct | |
| Sep 16, 2024 | Common Stock | SSaleDisposed | −1,150 | $0.69 | −$793.5 | 51,666 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2024 | Common Stock | MOption exerciseDisposed | −2,609 | $0.00 | $0 | 15,657 | Direct | |
| Sep 15, 2024 | Common Stock | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 35,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.